Stocks
Immunome (IMNM) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -9.72 | -17.0 | -23.9 | -36.3 | -28.3 | -119.9 | ||
| Changes by years, y/y, % | +35% | +75% | +41% | +51% | -22% | +31.5% | |||
Immunome. EBITDA US GAAP, bln rub
Immunome. EBITDA US GAAP, changes, %
Immunome. EBITDA US GAAP, sum by quarters, bln rub
Immunome (IMNM) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -4.52 | -13.7 | -20.2 | -35.4 | -50.5 | -119.9 | |
| Changes by years, y/y, % | -46% | +82% | +352% | +531% | +1 017% | |||
| Changes by quarters, q/q, % | -19% | +203% | +47% | +76% | +43% | |||
